Join the Oncology Voice Network. Join for Free
Season 1, Episode 13: Leadership Through Vulnerability with Gwen Binder

Season 1, Episode 13: Leadership Through Vulnerability with Gwen Binder


Share This Article


In today's episode our host Michael Pietrack sits down with Gwendolyn Binder, President of Science and Technologies at Cabaletta Bio, shares her insights on leadership. She discusses how she became an accidental leader and the importance of focusing on advancing the ball for patients rather than personal recognition. Binder emphasizes the need for leaders to embrace uncertainty and have an entrepreneurial attitude. She also highlights the importance of unleashing the potential of others and aligning a unified vision. Binder discusses the role of culture in leadership and the need for leaders to be vulnerable and create a teamwork culture. She provides tips for hiring and emphasizes the importance of no-regret hires. "Instead of trying to think how can I climb the ladder, it's how can I be of most use continually?" Binder also addresses the challenges and advice for female leaders. Tune in to hear it all!

Takeaways

🏀Focus on advancing the ball for patients rather than personal recognition.

🤗Embrace uncertainty and have an entrepreneurial attitude.

💹Unleash the potential of others and align a unified vision.

➡⬅Create a teamwork culture by being vulnerable and open.

☑Make no-regret hires by assessing cultural fit and soft skills.

🚺Acknowledge and address the challenges faced by female leaders. 

Watch on YouTube

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Prediction of Drug Approval After Phase I Clinical Trials in Oncology: RESOLVED2
OVN Avatar Guillaume Beinse, MD, Virgile Tellier, Valentin Charvet, MSc, Eric Deutsch, MD, PhD, Isabelle Borget, PharmD, PhD, Christophe Massard, MD, PhD., Antoine Hollebecque, MD, PhD, and Loic Verlingue, MD

Prediction of Drug Approval After Phase I Clinical Trials in Oncology: RESOLVED2

Article
Oncology approvals in 2020: a year of firsts in the midst of a pandemic
OVN Avatar Laleh Amiri-Kordestani & Richard Pazdur

Oncology approvals in 2020: a year of firsts in the midst of a pandemic

Article
Real-World Evidence in Oncology: Opportunities and Limitations
OVN Avatar Massimo Di Maio, Francesco Perrone, Pierfranco Conte

Real-World Evidence in Oncology: Opportunities and Limitations

Article
Accelerated drug approvals in oncology: Pros and cons
OVN Avatar Thakur, Sayanta & Lahiry, Sandeep

Accelerated drug approvals in oncology: Pros and cons

Article
Pediatric Oncology Clinical Trials and Collaborative Research in Africa: Current Landscape and Future Perspectives
OVN Avatar Jaques van Heerden, MD, Mohamed Zaghloul, MD, Anouk Neven, MSc, Teresa de Rojas, MD, PhD, Jennifer Geel, MD, Catherine Patte, MD, Joyce Balagadde-Kambugu, MD, Peter Hesseling, MD, Francine Tchintseme, MD, Eric Bouffet, MD, and Laila Hessissen, MD

Pediatric Oncology Clinical Trials and Collaborative Research in Africa: Current Landscape and Future Perspectives

Podcast
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
OVN Avatar The Oncology Nursing Podcast

Patient Education for Next-Generation Sequencing to Guide Cancer Therapy

Explore OVN